{
  "docId": "019de075-d132-769f-97bd-4a840dd24899",
  "docSlug": "9e6f6ffb1a7ecb278276dcbd68bd1d77",
  "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides",
  "authorId": "aeglea-biotherapeutics",
  "authorName": "Aeglea BioTherapeutics",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-09-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 9,
  "pageCount": 56,
  "prevPage": 8,
  "nextPage": 10,
  "slideType": "key_messages",
  "function": "present_framework",
  "density": "sparse",
  "nDataPoints": 0,
  "notes": "The slide uses a numbered list format to present strategic pillars.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-d132-769f-97bd-4a840dd24899/9",
  "deckHref": "/decks/019de075-d132-769f-97bd-4a840dd24899",
  "deckJsonHref": "/decks/019de075-d132-769f-97bd-4a840dd24899.json",
  "deckAnchorHref": "/decks/019de075-d132-769f-97bd-4a840dd24899#slide-9",
  "components": [
    {
      "bbox": {
        "h": 0.5,
        "w": 0.86,
        "x": 0.07,
        "y": 0.35
      },
      "kind": "list",
      "text": "1. Best-in-class mAb engineering (With half-life extension technology) 2. Rational therapeutic combinations 3. Precision patient selection",
      "attrs": null,
      "subkind": "numbered",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e2cc370f-4f51-4aa7-b584-e2fa47f6fb29",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.58,
        "x": 0.21,
        "y": 0.24
      },
      "kind": "title",
      "text": "Three strategic pillars in an effort to create the preeminent IBD company",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "45471586-9299-4d5b-aeb0-1b8d53e3bb7a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.45,
        "x": 0.02,
        "y": 0.04
      },
      "kind": "title",
      "text": "Spyre's strategy to address unmet needs in IBD",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8a7ee25b-a026-4f37-9bfa-2d23bdc362d8",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Three Pillars",
      "slug": "three-pillars",
      "agent": "Architect",
      "layer": "slide",
      "matchId": "079815c0-bc8b-483e-ab72-674b81c36407",
      "evidence": "list/numbered: 1. Best-in-class mAb engineering (With half-life extension technology) 2. Rational therapeutic combinations 3. Precision patient selection",
      "confidence": 0.8
    }
  ],
  "frameworks": [
    {
      "name": "list-presentation",
      "slug": null,
      "matchId": "8ae7a5c2-aabb-477d-bd18-a3e3cbfdc527",
      "evidence": "Numbered list of strategic pillars",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 15,
      "from": 8,
      "beatId": "144f6fae-7163-4a94-a570-0f4d3bd78808",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Agitate (Make it worse)",
      "beatSlug": "problem-agitate-solution-agitate-make-it-worse",
      "evidence": "The document highlights the growing market and the need for improved solutions, emphasizing the limitations of current treatments.",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Development",
      "parentBeatSlug": "development"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}